The 27 analysts offering 1 year price forecasts for 4BIIB have a max estimate of — and a min estimate of —.
Analyst rating
Based on 36 analysts giving stock ratings to 4BIIB in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
4BIIB EPS for the last quarter is 3.66 EUR despite the estimation of 3.39 EUR. In the next quarter EPS is expected to reach 3.17 EUR. Track more of BIOGEN financials and stay on top of what is up with the company.
In the next quarter BIOGEN revenue is expected to reach 2.23 B EUR. Check out BIOGEN revenue and earnings and make informed decisions.
According to analysts, 4BIIB price target is 234.96 EUR with a max estimate of 315.67 EUR and a min estimate of 166.14 EUR. Check if this forecast comes true in a year, meanwhile watch BIOGEN stock price chart and keep track of the current situation with 4BIIB news and stock market news.
We've gathered opinions of 36 analysts rating 4BIIB stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.